FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hetero Labs, Ltd. - Unit III Indomethacin Capsules Recall

Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber…

Hetero Labs, Ltd. - Unit III · Hyderabad, N/A

Risk level
Class II
Reported by FDA
Aug 8, 2018
Recall ID
D-1019-2018
Check your lot numberHow we source this data

Summary

Hetero Labs, Ltd. - Unit III recalled Indomethacin Capsules starting Jul 18, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1019-2018 on Aug 8, 2018. Reason: Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.

Product description

Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01.

Lot numbers, UPCs & expiration codes

Lot #: E180315, Exp 12/19

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1019-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 18, 2018
FDA report date
Aug 8, 2018
Quantity
18,288 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero Labs, Ltd. - Unit III

Original FDA data

Every field from FDA enforcement report D-1019-2018, exactly as published.

Show all FDA fields
City
Hyderabad
Status
Terminated
Country
India
Event ID
80589
Address
Plot 22-110, Part Ii, Ida
Address (line 2)
Rangareddy, Jeedimetla
Code information
Lot #: E180315, Exp 12/19
Report date
Aug 8, 2018
Product type
Drugs
Recall number
D-1019-2018
Classification
Class II
Recalling firm
Hetero Labs, Ltd. - Unit III
Product quantity
18,288 bottles
Termination date
Jul 15, 2021
Reason for recall
Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 18, 2018
Initial firm notification
Letter
Center classification date
Jul 27, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1019-2018, published Aug 8, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls